Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis

Objective To analyse mortality trends of liver diseases in China over the past 30 years.Design Age-period-cohort analyses were applied to liver diseases data obtained from the Chinese Health Statistics Annual Report (1987–2001) and the Chinese Health Statistics Yearbook (2003–2017).Setting General p...

Full description

Saved in:
Bibliographic Details
Main Authors: Chaojie Liu, Yang Sun, Jie Chang
Format: Article
Language:English
Published: BMJ Publishing Group 2019-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/11/e029793.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110941788635136
author Chaojie Liu
Yang Sun
Jie Chang
author_facet Chaojie Liu
Yang Sun
Jie Chang
author_sort Chaojie Liu
collection DOAJ
description Objective To analyse mortality trends of liver diseases in China over the past 30 years.Design Age-period-cohort analyses were applied to liver diseases data obtained from the Chinese Health Statistics Annual Report (1987–2001) and the Chinese Health Statistics Yearbook (2003–2017).Setting General population in mainland China.Outcomes Mortality rates and age, period and cohort effects on three categories of liver diseases: primary liver cancer (PLC), chronic liver disease and cirrhosis (CLD), and viral hepatitis (VH).Results A total of 13.54 million deaths were attributable to liver diseases over the period between 1987 and 2016, resulting in an average of 36.15 deaths per 100 000 population per year. The risk of PLC mortality increased by 32.69% over the period after controlling for the effects of age and birth cohort. By contrast, the risk of CLD mortality decreased by 56.64% over the same period. The risk of VH mortality decreased first, followed by a resurgence after the period of 2002–2006. Similar mortality risk trends by age (increasing) and birth cohort (decreasing) were observed for PLC and CLD. The year 1952 represented a turning point for VH, with people born after 1950 experiencing a declining risk of VH mortality.Conclusions China has achieved great success in reducing the mortality of VH and CLD. However, significant challenges lie ahead in the efforts to prevent and control PLC and the resurgence of VH.
format Article
id doaj-art-050c21765dcf44978d301ef5a368cc8d
institution OA Journals
issn 2044-6055
language English
publishDate 2019-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-050c21765dcf44978d301ef5a368cc8d2025-08-20T02:37:43ZengBMJ Publishing GroupBMJ Open2044-60552019-11-0191110.1136/bmjopen-2019-029793Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysisChaojie Liu0Yang Sun1Jie Chang2School of Psychology and Public Health, La Trobe University, Bundoora, Victoria, Australia2 Center for Health Governance Research, Wuhan University, Wuhan, ChinaDepartment of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, ChinaObjective To analyse mortality trends of liver diseases in China over the past 30 years.Design Age-period-cohort analyses were applied to liver diseases data obtained from the Chinese Health Statistics Annual Report (1987–2001) and the Chinese Health Statistics Yearbook (2003–2017).Setting General population in mainland China.Outcomes Mortality rates and age, period and cohort effects on three categories of liver diseases: primary liver cancer (PLC), chronic liver disease and cirrhosis (CLD), and viral hepatitis (VH).Results A total of 13.54 million deaths were attributable to liver diseases over the period between 1987 and 2016, resulting in an average of 36.15 deaths per 100 000 population per year. The risk of PLC mortality increased by 32.69% over the period after controlling for the effects of age and birth cohort. By contrast, the risk of CLD mortality decreased by 56.64% over the same period. The risk of VH mortality decreased first, followed by a resurgence after the period of 2002–2006. Similar mortality risk trends by age (increasing) and birth cohort (decreasing) were observed for PLC and CLD. The year 1952 represented a turning point for VH, with people born after 1950 experiencing a declining risk of VH mortality.Conclusions China has achieved great success in reducing the mortality of VH and CLD. However, significant challenges lie ahead in the efforts to prevent and control PLC and the resurgence of VH.https://bmjopen.bmj.com/content/9/11/e029793.full
spellingShingle Chaojie Liu
Yang Sun
Jie Chang
Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
BMJ Open
title Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
title_full Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
title_fullStr Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
title_full_unstemmed Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
title_short Mortality trends of liver diseases in mainland China over three decades: an age-period-cohort analysis
title_sort mortality trends of liver diseases in mainland china over three decades an age period cohort analysis
url https://bmjopen.bmj.com/content/9/11/e029793.full
work_keys_str_mv AT chaojieliu mortalitytrendsofliverdiseasesinmainlandchinaoverthreedecadesanageperiodcohortanalysis
AT yangsun mortalitytrendsofliverdiseasesinmainlandchinaoverthreedecadesanageperiodcohortanalysis
AT jiechang mortalitytrendsofliverdiseasesinmainlandchinaoverthreedecadesanageperiodcohortanalysis